Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 6, 2023JAMA NeurologyOpen Access

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

SMStéphanie MeierUniversity Hospital of BaselEWEline A.J. WillemseUniversity of BaselSSSabine SchaedelinUniversity of Basel

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meier et al. (2023) studied this question.

synapsesocial.com/papers/69dca71598c6111533e535abhttps://doi.org/10.1001/jamaneurol.2022.5250
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis2009 · 555 citations
  2. 2Multiple Sclerosis: Destruction and Regeneration of Astrocytes in Acute Lesions2019 · 44 citations
  3. 3Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis2021 · 59 citations
  4. 4High or increasing serum NfL is predictive of impending multiple sclerosis relapses2022 · 73 citations
  5. 5Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.475 citations